Medical Equipment

Best Prospects in the Influenza Diagnostics Market and Strategies for Growth – Includes Influenza Diagnostics Market Size

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!


Major players in the influenza diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Quidel Corp.


TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.


The influenza diagnostics market is expected to reach from $2.26 billion in 2021 to $3.15 billion in 2026 at a rate of 6.8%. The influenza diagnostics market size is then expected to grow at a CAGR of 6.8% from 2026 and reach $4.37 billion in 2031.


North America was the largest region in the global influenza diagnostics market.


The influenza diagnostics market consists of sales of diagnostic tests and related services by entities (organizations, sole traders and partnerships) that are used to detect and to diagnose influenza. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue and headache.


Increasing healthcare expenditure is predicted to drive the demand for influenza diagnostics.


Request a Sample of the Influenza Diagnostics Market Report


Artificial Intelligence is being increasingly incorporated with rapid diagnostic test kits to increase the efficiency of diagnosis. Artificial intelligence (AI) refers to the simulation of human intelligence in computer-controlled machines that are programmed to perform tasks, which usually require human intelligence. Artificial Intelligence algorithms are being used to integrate the findings of clinical symptoms, exposure history, and laboratory testing to increase the chance of early detection of influenza infection.


TBRC’s Influenza Diagnostics Market Report Segments:
By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Others

By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Others

By End User: Hospitals and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others
By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.


The Influenza Diagnostics Market Report 2022–Opportunities And Strategies – Global Forecast To 2031 is one of a series of new reports from The Business Research Company that provides an overview of the influenza diagnostics market globally and regionally, analyzes and forecasts market size, share, influenza diagnostics market players, influenza diagnostics market segments, leading competitor revenues, profiles and market shares.


Here Is A List Of Similar Reports From The Business Research Company:

Molecular Diagnostics Devices And Equipment Global Market Report 2022

Point-Of-Care Molecular Diagnostics Global Market Report 2022

PCR And Realtime PCR Testing Global Market Report 2022


Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.


Read more about us at


Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Global Market Model:


Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *